Although knowledge of the coordination
chemistry and metal-withholding
function of the innate immune protein human calprotectin (hCP) has
broadened in recent years, understanding of its Ca2+-binding
properties in solution remains incomplete. In particular, the molecular
basis by which Ca2+ binding affects structure and enhances
the functional properties of this remarkable transition-metal-sequestering
protein has remained enigmatic. To achieve a molecular picture of
how Ca2+ binding triggers hCP oligomerization, increases
protease stability, and enhances antimicrobial activity, we implemented
a new integrated mass spectrometry (MS)-based approach that can be
readily generalized to study other protein–metal and protein–ligand
interactions. Three MS-based methods (hydrogen/deuterium exchange
MS kinetics; protein–ligand interactions in solution by MS,
titration, and H/D exchange (PLIMSTEX); and native MS) provided a
comprehensive analysis of Ca2+ binding and oligomerization
to hCP without modifying the protein in any way. Integration of these
methods allowed us to (i) observe the four regions of hCP that serve
as Ca2+-binding sites, (ii) determine the binding stoichiometry
to be four Ca2+ per CP heterodimer and eight Ca2+ per CP heterotetramer, (iii) establish the protein-to-Ca2+ molar ratio that causes the dimer-to-tetramer transition, and (iv)
calculate the binding affinities associated with the four Ca2+-binding sites per heterodimer. These quantitative results support
a model in which hCP exists in its heterodimeric form and is at most
half-bound to Ca2+ in the cytoplasm of resting cells. With
release into the extracellular space, hCP encounters elevated Ca2+ concentrations and binds more Ca2+ ions, forming
a heterotetramer that is poised to compete with microbial pathogens
for essential metal nutrients.